jason370 said:
Does anyone have what they believe to be one solid source of truth resource for how to thoughtfully build a peptide stack? Preferably one which considers the metabolic lanes, so one doesn't overcrowd any given lane?
(I apologize in advance for the lack of humility. I simply wish to paint a picture that even the most qualified among us struggle to find clarity in this crazy world of peptides)
I am a data scientist. I'm a highly skilled researcher. I run risk management via quantitative analysis for the top 100 hedge funds in the world, and i regularly tell the smartest MIT educated PHd. mathematicians how and why they are wrong about their math, research, and work approach, in front of their bosses - that's what i do all day. The smartest and most successful (those two things do not necessarily go together) people on Wall st refer to guys like me as the really smart guys.
And yet still...
I have no clear answers on what or how to stack peptides in any manner which gives me real confidence. Yes i have a ton of information, yes I've read it all. I've referred to:
Every A.I.
The entirety of the internet
This forum
Peppys
STG
Myriad TG and Discord groups
My Endocrinologist
My GP
My friends who are doctors
My friends who just use a ton of peptides
I've posted a lot in the last couple months
I built a peptide tacker management tool/app as well
And more.
For example:
My best understanding is there are four metabolic lanes for peptide use . I wonder how many people even know this most fundamentally important piece of information. Since there are four lanes, if one wishes to address concerns/issues/interests in said lanes, it is my best understanding one should only use one peptide per lane (per day, if it is a daily usage pep? this part becomes unclear to me).
Reta/Cagri: do they occupy the same lane? are they different lanes? if same then what protocol would ensure the best results? No need to directly answer this scenario, it is an example of a more complicated protocol to figure out>
Tesa/CJC-IPA: similar situation, except these are daily pins occupying the same lane. Should one alternate tesa MWF and CP10 TuTh Sat? Would that be the ideal solution or is this combination simply a bad idea.
Klow in am, Wolverine at night: seems redundant in some ways, but if you have a specific injury perhaps one might want to c=double up a bit to address that. It's complicated.
These scenarios are endless, yet perhaps a lane tool could be build, or perhaps it exists already, which might help narrow down these decisions, rather than just relying on 31 posts that describe unique scenrios.
I'm all but certain I speak for many (maybe most) here. I've been running my stack for a few months, it's going well, i feel great but I also know I'm just experimenting here. I happen to have an extremely high risk tolerance so I don't exactly mind, but It's bothering me that there is no reliable source of truth for something which seems quite straightforward.
Any constructive feedback would be greatly appreciated.
There is vast difference in quality in the information sources you are listing, and AI responses to medical type questions vary tremendously on prompting,. Default options will usually prefer coherent stories over scientific accuracy and agreement with the questioner, and if more text on the internet is in reddit forums than in scientific papers, more of the AI answers will derive from the text from reddit, unless careful prompting is used.
The obvious issue is you are trying to find high certainty information, in an area where a lot of it is just made up marketing crap, and where the science that could provide that certainty does not exist, for the vast majority of popular peptides with the exception of GLP's.
I do not believe anecdotal evidence online of miraculous cures by products like KLOW or GLOW are evidence that they work. It is interesting, but there are many different reasons why this could happen, and those anecdotal experiences are true, even if the drugs do nothing.
The sole source of high certainty information is the original scientific research papers. An AI prompted to give answers consistent with that of a careful researcher is going to say that using peptides either not studied in humans or poorly studied in humans is intrinsically unsafe, and extrapolating from animal research is not a valid basis for human therapies. I think the lack of medical research reading is an issue here, it is different and has different sets of rules and priorities to many other scientific areas, and developing the skill to understand and distinguish between research that is interesting or suggestive versus definitive is genuinely hard and takes time and experience.
The only valid and definitely reliable evidence to support a particular peptide combination is a prospective controlled clinical trial of that combination in humans, and this information does not exist ( maybe cagrisema ).
What exists at best for most peptides is usually small human trials in limited specific populations, which may or may not apply to people outside of those specific groups. So for tesamorelin for example there are several smallish human trials saying it was useful for lipodystrophy in HIV patients. And in general , that is all that can be said to be proven. It does not prove it is safe or effective in the general population or other specific groups. It is not totally unreasonable to extrapolate from that known information that it has a reasonable chance of doing the same thing in other populations, and that given there were no major adverse effects that were unexpected in that group that this might be the case in a more general population. For a medication to be approved for human use, it needs that level of proof of safety and efficacy, so it is approved to treat HIV patients with lipodystrophy but nothing else. The logic applied to establishing drug safety and effectiveness is a complex evolved system, where other science logics are not necessarily the same.
You state you have high risk tolerance, and to use those peptides that is required, as the evidence and especially evidence that is certain or reliable is very sparse. And for the majority of the available peptides there are no human trials. Trying to extract high certainty data out of low certainty information, such as online posts is effectively not possible.